Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

• Status: Completed
• Trial end date: 2006-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Atomoxetine Hydrochloride; Buspirone

Criteria

Inclusion Criteria:

• Adults with ADHD

Exclusion Criteria:

• Other Axis I Psychiatric Disorders